All prescription drugs that desire to be marketed in the U.S. must gain the approval of the Food and Drug Administration (FDA). Through the Center for Drug Evaluation and Research (CDER), which assures that safe and effective drugs are available to the American people, a prescription drug must pass a series of trials. Please understand that the FDA does not develop, manufacture or test drugs. Drug manufacturers submit full reports of a drug’s studies to the CDER so that the Center can evaluate its data. The studies answer the question, “Does this drug work for the proposed use?” By analyzing the data, CDER reviewers assess the benefit-to-risk relationship and determine if the drug will be approved. Once the drug has been placed on the market, the FDA continues to monitor it through post-marketing reports sent in by the manufacturer and through the MedWatch program – an FDA program that allows consumers and health care professionals to report serious side effects, quality control issues, and medical errors associated with drugs and products regulated by the FDA.

Sometimes, an unanticipated side effect manifests itself once the drug has been made available to the U.S. market. If the side effect is serious enough, the FDA may issue a warning to the public and request that changes be made to the drug’s label. If the side effect is extremely serious and the FDA decides that the risks of the drug outweigh its benefits, then the FDA may recall the drug.

Speak to a Lawyer

Each year, thousands of people die from or are seriously injured by prescription drugs, over-the-counter drugs and medical devices they believe to be safe. If you or a loved one have taken a defective drug, experienced problems with a defective medical device or used a defective product, then contact our law firm immediately. Consult an attorney privately to learn your legal rights. All information is held in the strictest of confidence.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Legal help: Contact an Attorney

Recent studies as well as FDA adverse event reports have linked transvaginal mesh surgery for stress urinary incontinence and pelvic organ prolapse to high risks of complications, like mesh erosion. Medical device manufacturer Boston Scientific is one of four major companies that develops and distributes this problematic type of transvaginal mesh. One such model is called the Solyx SIS System, which is a sling made of Advantage Mesh and is used to treat stress urinary incontinence. Unfortunately, the Solyx System as well as all other transvaginal mesh product can result in serious complications that can require hospitalization and revision surgeries. In many patients, even a second surgery cannot fully fix the problem of mesh erosion, and the quality of life for the victim is permanently diminished.

Other Boston Scientific Transvaginal Mesh Products

The Solyx SIS System is not the only mesh device that has been developed and created by the Boston Scientific Corporation. Currently, Boston Scientific has all of the following mesh products available for the treatment of either pelvic organ prolapse, stress urinary incontinence and/or vaginal wall prolapse:

• Advantage Fit System
• Advantage Transvaginal Mid-Urethral Sling System
• Lynx Suprapubic Mid-Urethral Sling System
• Obtryx Transobturator Mid-Urethral Sling System
• Pinnacle Pelvic Floor Repair Kit
• Pinnacle Posterior Pelvic Floor Repair Kit
• Prefyx PPS System
• Solyx SIS System
• Uphold Vaginal Support System

Boston Scientific Solyx FDA Warning

In January of 2012, the United States Food and Drug Administration is considering that transvaginal surgical mesh be reclassified from Class II to Class III when used in treatment for stress urinary incontinence and pelvic organ prolapse. This decision was based on information collected from adverse event reports of vaginal mesh complications, medical literature published on the subject, as well as the September 2011 meeting of the Obstetrics-Gynecology Devices Panel. Furthermore, the FDA has mandated postmarket studies the manufacturers of transvaginal mesh used in both SUI and POP treatment. As soon as further information is discovered regarding Boston Scientific Solyx and other devices, the FDA will make it available to the public.

File a Boston Scientific Transvaginal Mesh Lawsuit: Speak to an Attorney

Many women who suffer from mesh erosion and other bladder sling complications find themselves bombarded with medical expenses as the result of their injuries. If you have been hurt as the result of treatment with the Solyx SIS System or other type of transvaginal mesh, call the Willis Law Firm today. We may be able to help you secure financial damages in relation to your situation; currently we are looking at mesh cases nationwide. Call us today.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Legal help: Contact an Attorney

A woman in Pennsylvania recently filed a lawsuit against Boston Scientific Corporation alleging that one of their products, the Advantage Fit System, caused her serious physical complications. The woman was treated with the transvaginal mesh product in 2009 to help with her issue of stress urinary incontinence, an involuntary urine leakage problem that affects many women. According to her mesh lawsuit claim, the woman began to experience pain, bleeding, and extreme discomfort during intercourse shortly following her initial Advantage Fit SUI treatment. These complications related to transvaginal mesh have been described as “not rare,” by the US Food and Drug Administration in various safety communications and warnings. The Pennsylvania Boston Scientific Advantage Fit Lawsuit plaintiff underwent a transvaginal mesh revision surgery in 2010, but continued to experience mesh complications including: stomach pain, bleeding, and infections. As a result of these continuing discomforts as well as the medical expenses required for treatment, a mesh erosion lawsuit claim was filed.

Boston Scientific Advantage Fit FDA Warning

In October of 2008, the United States Food and Drug Administration alerted the public to the complications connected to transvaginal mesh surgery for pelvic organ prolapse and stress urinary incontinence. In the three years prior to the FDA mesh warning, over one thousand adverse event reports were filed in relation to surgical mesh. Between 2008-2010, this number grew closer to 3000. When another FDA transvaginal mesh warning was made in 2010, vaginal mesh complications and mesh erosion were named as “an area of continuing serious concern.” The FDA is still collecting data and reviewing studies regarding Boston Scientific Advantage Fit as well as all other transvaginal mesh sling devices.

Boston Scientific Advantage Fit Complications

• Mesh erosion (when the mesh protrudes through vaginal walls)
• Vaginal Pain
• Mesh contraction (when the mesh shrinks)
• Organ perforation (can occur during surgery)
• Pain during intercourse
• Reoccurrence of SUI and/or POP
• Vaginal Scarring
• Emotional problems

File a Boston Scientific Advantage Fit Lawsuit: Consult with an Attorney

Treatment with Boston Scientific Advantage Fit and other transvaginal mesh slings presents additional risks that are not present in other non-mesh forms of treatment for SUI and POP. If you have suffered injuries resulting from surgical mesh, you may have a potential lawsuit claim. Call the Willis Law Firm in order to have your case evaluated free of charge or obligation by a female member of our talented legal team. At present, we are accepting vaginal mesh clients nationwide.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Legal help: Contact an Attorney

Recently the US Food and Drug Administration has issued several safety communications regarding high risks of serious complications associated with transvaginal mesh, like Ethicon’s Gynecare Prolift System. Many lawsuits have been filed against Ethicon, a division of Johnson & Johnson, by patients who have suffered from painful and even life-threatening adverse effects. Transvaginal mesh bladder slings are used in the treatment of pelvic organ prolapse as well as stress urinary incontinence. However, the FDA has stated that although they pose extra risks to patients, they do not necessarily work better than other non-mesh treatment options.

What is the Ethicon Gynecare Prolift System?

The Gynecare Prolift Pelvic Floor Repair system is a vaginal mesh bladder sling device produced and marketed by Johnson & Johnson’s Ethicon division for the treatment of pelvic organ prolapse. Pelvic organ prolapse (POP) is a condition that takes place when various tissues that hold the organs in the pelvic region become stretched out or weakened. POP can affect the uterus, rectum, bowels, bladder, and vaginal apex. The Gynecare Prolift mesh is transvaginal, meaning that it is inserted through the vagina, and helps to restore support to organs that have prolapsed. Unfortunately, using transvaginal mesh, like the Gynecare Prolift System, can result in harmful complications including: infection, urinary problems, mesh erosion, and others.

Ethicon Gynecare Prolift System Complications

The side effects and complications that can result from transvaginal mesh treatment can seriously affect a patient’s quality of life. The most commonly reported complication with Gynecare Prolift and other similar devices is called mesh exposure, and occurs when the mesh erodes through the vaginal wall. When this erosion takes place, the result is very painful, especially during sexual intercourse. Treatment for these Gynecare Prolift complications often requires a revision surgery in order to remove the mesh, as well as IV treatment and possibly even blood transfusions. Sometimes, even a second surgery cannot fully remove the mesh.

File a Ethicon Gynecare Prolift Lawsuit: Speak to an Attorney

Have you experienced transvaginal mesh erosion or other complications following treatment with the Gynecare Prolift System or similar device? If so, you may be legally entitled to significant financial damages. Call the Willis Law Firm today and we will provide you with a free and confidential Gynecare Prolift Lawsuit Evaluation. Our firm is currently reviewing vaginal mesh cases nationwide, and we have a team of female consultants ready to discuss these sensitive women’s health issues with you in confidence. Call us today, and get the help you need.

Contact a Drug Lawsuit Lawyer & Attorney

For a free and confidential consultation, fill out our online case evaluation form or call us toll free at: 1-800-883-9858.

Legal help: Contact an Attorney

Taking Zoloft while pregnant may lead to an increased risk of several different types of birth defects, many which are potentially life threatening. Over the past few years Zoloft has been linked to congenital heart defects, stomach/abdominal wall defects, cranial/skull defects, Autism Spectrum Disorders, and several other devastating medical conditions. The FDA has released a safety communication regarding the increased risk of one of these conditions, Persistent Pulmonary Hypertension of the Newborn (PPHN). Unfortunately, the FDA still allows for the treatment of pregnant women with this type of antidepressant medication despite these risks.

FDA Pregnancy Categories

Currently, the United States Food and Drug Administration uses a category system in order to rank and evaluate the safety of various drugs taken during pregnancy. This category system was introduced in the year 1979, and many other countries have implemented similar systems. This is because many drugs are tetrogens, which means that they could potentially harm a developing child. Zoloft (sertraline) is in the FDA’s “Pregnancy Category C,” which means that in animal studies, the drug has demonstrated harm/adverse effect to the developing child, but sufficient studies have not been performed using humans. Another similar antidepressant, Paxil, was recently reclassified as “Pregnancy Category D,” after new studies and market research demonstrated an adverse effect to human fetus.

Zoloft FDA Alert Lawsuits

Because taking Zoloft while pregnant has demonstrated increased risk of birth defects in several studies, many families choose to file a Zoloft lawsuit against Pfizer in order to help alleviate some of the financial burden that these injuries result in. A Zoloft lawsuit alleges that the manufacturer of the drug either did not perform sufficient testing prior to the release of the product, or that they failed in their duty to alert consumers regarding the potential for causing harm.

File a Zoloft Lawsuit: Speak to an Attorney

If your child was born with a birth injury and the mother was prescribed an antidepressant medication like Zoloft during the pregnancy, you and your family may be legally entitled to a financial settlement. Call the Willis Law Firm today in order to find out whether a Zoloft lawsuit is the right choice for you and your child. We are currently reviewing antidepressant birth defect cases in all 50 states regarding the following antidepressant medications:

• Zoloft
• Paxil
• Lexapro
• Celexa
• Effexor
• Prozac

Call today for your free and confidential case evaluation; all birth defect clients are taken on a contingency fee basis which means that you will not be billed any legal fees unless a recovery is made in your favor.

According to recent studies conducted by the United States Food and Drug Administration (FDA) and other groups, taking popular antacids like the purple pill Nexium for longer than a year may increase the risk of hip fractures significantly, especially in people over age 50. Nexium is one of the most commonly used prescription drugs on the entire market, taken by millions of individuals annually.

The medical professionals analyzing Nexium hypothesized that the same qualities of the drug that minimize the amount of acid in the stomach also prevent the body from absorbing an adequate amount of calcium. Calcium is essential to the development and maintenance of healthy bones in the body. This deterioration of the bones has led to reported weaker bones and Nexium related hip fractures.

Among the elderly, hip fractures may often lead to life-threatening complications. Until recently, the general perception of drugs like Nexium was that they were basically harmless. Bone fractures, more specifically hip fractures, were not listed as possible Nexium side effects when the drug was originally released and approved. The Food and Drug Administration’s (FDA) latest warning now requires Nexium and other antacids to carry a special warning on the drugs’ label about potential bone fractures including Nexium hip fractures.

For many people suffering from heartburn, they are able to find relief from over-the-counter remedies like Tums or Rolaids, but for some these over-the-counter medicines are not adequate. According to one study, patients who used drugs like Nexium for more than a year had a 44% higher chance of hip fractures than nonusers. The study claims that the longer a patient takes Nexium, the higher the risk of hip fractures. Many patients have been taking Nexium for years without knowing the potentially dangerous side effects like hip and other bone fractures.

According to reported sales figures, Nexium is the second highest selling drug in the world with sales of more than $4.5 billion last year. The study also claims that men are at a higher risk of Nexium hip fractures than women. The researchers are unsure whether this difference is due to the fact that women may be more aware of the risks of osteoporosis or that they get more calcium in their diets.

Now that AstraZeneca, the maker of Nexium, is required to carry a special warning regarding Nexium hip fractures, many people wish that they had these warnings years ago. Nexium has been on the market for more than 10 years, so there are likely very many cases of Nexium hip fractures in which the patients had no idea what caused their painful hip fractures.

Nexium Lawsuit – Speak to an Attorney

Have you or a loved one suffered from bone fractures, hip fractures, bone loss, bone density loss, or osteoporosis which you think may be attributed to taking AstraZeneca’s Nexium? If so, you may be entitled to compensation from the makers of Nexium. Our Nexium lawyers are currently accepting Nexium hip fracture lawsuits for individuals suffering from bone fractures, bone loss, and osteoporosis caused by prescription Nexium. Please call today to see if you have grounds for a Nexium hip fracture lawsuit

When choosing a surgical procedure as a treatment method for pelvic organ prolapse or stress urinary incontinence, the last thing that a woman wants is a complication that requires further surgery. Unfortunately, many women who receive transvaginal mesh surgery for POP and SUI will experience “mesh erosion,” a very painful complication that necessitates invasive (and sometimes repeated) surgeries to correct. Alarmingly, some cases of mesh erosion can never completely be resolved even following multiple surgeries. This happens when the mesh further breaks apart during surgery, making it impossible to completely retrieve.

What is Mesh Erosion?

Mesh erosion happens when the materials of the mesh or bladder sling device are not accepted and incorporated by the various tissues in the pelvic area. Mesh, or surgical mesh, comes in both biologic and synthetic variations and is used to strengthen the weakened tissues that can lead to bladder pressure, POP and SUI. When the device erodes through the walls of the vagina, the results can be extremely painful. This pain is often increased during sexual intercourse; many of the partners of women with mesh erosion also report pain experienced to the penis during intercourse. As mentioned above, surgery is required to treat mesh erosion.

FDA Comments on Mesh Erosion

According to the United States Food and Drug Administration, the erosion of transvaginal mesh through the walls of the vagina is the “most common and consistently reported mesh-related complication” following this type of treatment. Between the years of 2005 and 2007, over one thousand women reported mesh complications to the FDA; shockingly between the years of 2008-2001 this number nearly tripled and the FDA received 2,874 adverse event reports regarding transvaginal mesh devices. In addition to mesh erosion, many other complaints regarding these products were filed ranging from vaginal scarring all the way to neuro-muscular problems. In response to these various complications, many women file mesh lawsuits in order to help them cover their treatment and emotional expenses.

File a Mesh Erosion Lawsuit: Speak to an Attorney

If you experienced mesh erosion or other complications following treatment with a transvaginal mesh or bladder sling device, you may have a legal entitlement to financial compensation. Call the Willis Law Firm today in order to receive valuable mesh erosion lawsuit information completely free and in confidence. We know that discussing these sensitive women’s issues can be potentially difficult, so we have a team of female consultants standing by for you. Although located in Houston, the Willis Law Firm is currently reviewing mesh erosion cases on a national level; all mesh erosion cases are taken on a contingency fee basis.

In December of 2011, the United States Food and Drug Administration (FDA) released a Safety Announcement regarding recent studies conducted about Pradaxa causing internal bleeding. The Food and Drug Administration (FDA) stated that they were evaluating post-marketing (after sale) reports of severe bleeding events reported in Pradaxa patients. Pradaxa is a popular anticoagulant on the market with billions in sales.

In Pradaxa’s first year on the market, there were more than 250 deaths reportedly caused by Pradaxa related to internal bleeding. Results like that are bound to catch the eye of the Food and Drug Administration (FDA) and sure enough, they are currently reviewing the effects of Pradaxa. The Pradaxa FDA Alert states that Pradaxa is a blood thinning drug meant to lower the risk of stroke in certain patients.

At this time there is currently no Pradaxa FDA recall in effect. The FDA alert states that the bleeding caused by Pradaxa may lead to very severe and even fatal complications in patients. The Food and Drug Administration (FDA) is currently seeking to determine if the Pradaxa internal bleeding reports are occurring at higher rates than normal.

Pradaxa has been submitted into the Food and Drug Administration’s (FDA) Adverse Events Reporting System (AERS) to further investigate what adverse effects may be caused by Pradaxa and to determine if these Pradaxa internal bleeding deaths are occurring at a higher rate than expected.

Pradaxa is a fairly new blood thinning drug on the market. Previous to Pradaxa, the most common anticoagulant treatment was warfarin. Pradaxa is preferred by many because it is believed to be easier to dose for patients, requiring fewer blood tests and less examination. However, if Pradaxa is causing significantly more internal bleeding deaths, then it may not be worth the risk.

One reason that warfarin is believed to be safer than Pradaxa is that in the event of warfarin internal bleeding; patients may supplement their intake with Vitamin K to offset much of the internal bleeding danger. For patients taking Pradaxa however, Vitamin K does not have the same negating effects on the internal bleeding.

The manufacturer of Pradaxa, German pharmaceutical company Boehringer Ingelheim, has admitted that roughly 260 cases of fatal internal bleeding have been linked to their drug Pradaxa. They claim that the number of Pradaxa deaths is below the average rate, but the trials are not conclusive. It is impossible to know if the 260 reported Pradaxa deaths are the only Pradaxa deaths which have occurred.

Pradaxa Lawsuit – Speak To a Lawyer

If you have suffered from internal bleeding or know of someone who has suffered or died from internal bleeding which you believe may be caused by Pradaxa, you may be entitled to financial compensation from the makers of Pradaxa. Potential Pradaxa internal bleeding lawsuits are currently being reviewed. Please contact our law firm immediately to see if you have a Pradaxa internal bleeding case.

The United States Food and Drug Administration is currently conducting an evaluation of an increased risk of blood clots associated with Yaz, a birth control pill that contains drospirenone. Yaz has already been the subject of FDA warnings before in 2008, when their television advertisements were deemed as misleading the public. Yaz’s commercials suggested that the drug had also been approved for the treatment of acne and PMS in addition to preventing pregnancy. In reality, neither of these claims was validated by evidence. Furthermore, the ads were criticized by the FDA as suggesting that Yaz was “safer” than other types of oral contraceptives without any substantial evidence or clinical proof. Recent studies have actually indicated that oral contraceptives with drospironine, including Yaz, actually carry with them higher risks of blood clots than other birth control methods.

Yaz Blood Clot Studies

Bayer claims that its product Yaz is “as safe and effective” as other birth control pills, and according to two clinical studies (both of which were funded by Bayer) this is true. However, four other independently conducted studies (not funded by Bayer) regarding Yaz found increased risks of blood clots. When presented with the evidence of one of these studies that used nearly 1 million women, Bayer chose not to respond. Fortunately, the FDA has not taken the same approach. When presented with the information of studies regarding this increased risk and its conflict with the studies conducted by Bayer, the FDA decided to fund its own study regarding these safety issues. The findings of the FDA study have not yet been released.

Yaz Lawsuit

When taking Yaz results in a blood clot, the results can be devastating. Deep vein thrombosis, one type of blood clot linked to Yaz, can sometimes result in a condition called a pulmonary embolism. Pulmonary embolisms can be life threatening, especially if not treated quickly. Other blood clots can lead to strokes as well as other serious medical problems. Many women who suffer these related injuries file a Yaz lawsuit against Bayer. These lawsuits often allege that Bayer was aware of these increased risks and did not warn them adequately. Furthermore, some Yaz lawsuits assert that Bayer actually tried to cover up related information in order to protect the company’s financial interests.

File a Yaz Lawsuit: Speak to an Attorney

If you have experienced a blood clot or related medical complication and were prescribed Yaz, you may have a legal right to financial compensation. Call the Willis Law Firm today, and we will provide you with a Yaz lawsuit evaluation free of cost or obligation. We accept all Yaz cases on a contingency fee basis, so you will not be responsible for any legal fees unless a recovery is made in your favor. Currently our firm is reviewing cases for the following birth controls containing drospironine on a national scale: Yaz, Yasmin, and Ocella.

On 7-13-2011, the FDA issued an update to warn of further complications and adverse effects connected to the transvaginal placement of surgical mesh. A previous warning was issued in 2008, but the emergence of new complications in numerous patients necessitated an official update to the original warning. The most up to date FDA warning also acknowledges that the complications associated with transvaginal mesh are not rare, which is a modification from the previous warning. The number of complaints regarding vaginal mesh almost tripled in the past 3 years, and is currently approaching a shocking 3000. Vaginal mesh has been found to expose patients to greater risk than other more traditional forms of non-mesh methods of vaginal repair. According to the FDA warning, the use of vaginal mesh is “an area of continuing serious concern.”

Vaginal Mesh Erosion Lawsuits

• ObTape Lawsuit
• Vaginal Mesh Erosion Warning by the FDA
• Bladder Sling Mesh Erosion Lawsuits
• ObTape Mesh Erosion Lawsuits
• Vaginal Mesh, Bladder Slings and ObTape Lawsuits
• Transvaginal Mesh Lawsuits

What is Vaginal Mesh?

Vaginal mesh and bladder slings along with ObTape are medical device composed of synthetic material implanted surgically for the treatment of stress urinary incontinence (SUI) and pelvic organ prolapsed (POP). Vaginal mesh treats stress urinary incontinence by supporting the urethra to prevent unexpected bladder leakage, and strengthens weakened vaginal walls for the treatment of pelvic organ prolapse. The mesh is supposed to be a permanent solution to these conditions, however for many women the distressing consequences result in further surgery for its removal. Often times, these patients were not adequately warned of the possible complications and had they been aware, they might have chosen an alternative device or treatment method. In many cases stress urinary incontinence and pelvic organ prolapsed can be treated successfully without the use of mesh. Furthermore, using vaginal mesh, bladder slings and Ob Tape can make further surgical repairs more challenging.

Vaginal Mesh Erosion

Vaginal mesh erosion happens when the vaginal mesh, bladder sling and Ob Tape actually grinds through the fragile tissue of the vaginal walls. Also referred to as extrusion or protrusion, mesh erosion is the most regular and repeatedly reported mesh-related concern. According to the FDA warning, expulsion is a complication limited to transvaginal mesh and can be avoided through the use of conventional non-mesh surgical methods. Mesh erosion can require multiple invasive surgeries to fix and can be incapacitating for some women. In a number of severe cases, multiple surgeries will not even fully resolve the complication. Other potential risks associated with vaginal mesh include, but are not limited to, pain during sexual intercourse, recurring vaginal discharge, and persistent vaginal bleeding.

Talk to a Vaginal Mesh Lawyer Today

Many patients suffering from vaginal mesh, bladder sling or Ob Tape complications wish that they had been adequately warned of the risks and potential complications before undergoing the operation. If you or a loved one is suffering from vaginal mesh injuries please call the Willis Law Firm. We have female consultants standing by, trained to discuss these sensitive issues confidentially. We are currently accepting vaginal mesh injury lawsuits nationwide. Our product liability law team at the Willis Law Firm is committed to getting you answers and financial compensation for your medical expenses, loss of income, physical pain, and emotional suffering. These cases are handled on a Contingency Fee Basis, which means that no attorney’s fees or any other expenses will be charged unless we recover for you. Call us toll free at 1-800-883-9858 for a free case evaluation about Filing a Lawsuit.

Only a week after officials in both France and Germany began restricting the prescriptions of the diabetes drug Actos made by Takeda Pharmaceuticals, the US Food and Drug Administration (FDA) will now require additional warnings that the use of Actos for more than a year might be linked with an increased risk of developing bladder cancer. Only a week prior, a French study with similar findings propelled French officials to suspend the use of Actos and officials in Germany have recommended that doctors not prescribe Actos to new patients.

The statement by the FDA is in response to a 5-year interim analysis of an ongoing 10-year study of Actos risk of bladder cancer. The FDA’s analysis claims that while they don’t see any overall increase risk of bladder cancer with the use of Actos, they noted an increased Actos bladder cancer risk among patients taking Actos for more than a year as well as those taking higher dosages of Actos. French and German studies, however, did claim that there is an overall increased risk of bladder cancer with Actos as well as an even higher risk the longer Actos is taken.

The French decision was made by its version of the FDA, the AFSSAPS which based their move on a study conducted by a national French insurer which examined results of more than 1.5 million individuals between the ages 40 and 79 years old being treated with Actos between 2006 and 2009. France’s move on Actos has triggered a study by the European Medicines agency, the umbrella drug regulatory agency of Europe. Their study is currently ongoing. A further report in an issue of Diabetes Care, reported 93 incidences of bladder cancer among Actos patients in the FDA Adverse Event Reporting system databases spanning between 2004 and 2009.

Between January 2010 and October 2010 more than 2.3 million patients filled a prescription for diabetes drug Actos. Actos has enjoyed great results following the restrictions placed on sister drug Avandia. Actos has been perceived as the ‘safer’ of the two diabetes drug, but new results linking Actos to bladder cancer might change that perception. In addition to being linked with bladder cancer, Actos has also been recently linked to increased heart failure and bone fractures.

Actos Bladder Cancer Lawsuit

If you or a family member took Takeda Pharmaceutical’s drug Actos (pioglitazone) and you have developed bladder cancer, we encourage you to contact a pharmaceutical lawyer at our firm immediately. An experienced pharmaceutical products liability lawyer at the Willis Law Firm can assist you in legal action in a potential Actos bladder cancer lawsuit against the makers of the drug.

Please fill out our online legal evaluation form to the right or call us and we will contact you within 4-12 hours for a free confidential case review. Contact our law firm immediately so that we may explain the rights and options available to you and your family.